Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.

Yervoy (ipilimumab) - BMS

Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) - BMS, Ono Pharmaceutical

http://www.ncbi.nlm.nih.gov/pubmed/42775742

Anna G Kondic; Elizabeth Gibson; Heather Vezina; Li Zhu; Yue Zhao; Zheyi Hu

Sep 24, 2026